Wood Trust Financial Corp Exact Sciences Corp Transaction History

Wood Trust Financial Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$62.68 - $95.05 $15,670 - $23,762	-250 Reduced 1.59%	15,437 $1.45 Million
Q4 2022 Jan 23, 2023	BUY	$30.35 - $53.15 $7,587 - $13,287	250 Added 1.62%	15,687 $777,000
Q2 2022 Jul 22, 2022	SELL	$35.61 - $76.23 $302,685 - $647,955	-8,500 Reduced 35.51%	15,437 $608,000
Q1 2022 Apr 25, 2022	BUY	$57.56 - $82.54 $1.19 Million - $1.71 Million	20,712 Added 642.23%	23,937 $1.67 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $27,187 - $37,755	375 Added 13.16%	3,225 $251,000
Q3 2021 Nov 08, 2021	BUY	$90.24 - $124.05 $44,939 - $61,776	498 Added 21.17%	2,850 $272,000
Q2 2021 Aug 03, 2021	BUY	$93.66 - $139.27 $9,553 - $14,205	102 Added 4.53%	2,352 $292,000
Q1 2021 Apr 22, 2021	SELL	$116.57 - $155.01 $29,142 - $38,752	-250 Reduced 10.0%	2,250 $297,000
Q3 2020 Oct 13, 2020	SELL	$72.92 - $102.01 $21,876 - $30,603	-300 Reduced 10.71%	2,500 $255,000
Q2 2020 Jul 29, 2020	BUY	$55.75 - $92.75 $156,100 - $259,700	2,800 New	2,800 $243,000
Q1 2020 Apr 07, 2020	SELL	$37.9 - $104.44 $94,750 - $261,100	-2,500 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$61.98 - $96.5 $154,950 - $241,250	2,500 New	2,500 $217,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Wood Trust Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Wood Trust Financial Corp with notifications on news.